Structure

Physi-Chem Properties

Molecular Weight:  700.18
Volume:  678.049
LogP:  5.473
LogD:  2.435
LogS:  -3.696
# Rotatable Bonds:  10
TPSA:  196.72
# H-Bond Aceptor:  14
# H-Bond Donor:  4
# Rings:  6
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.136
Synthetic Accessibility Score:  3.234
Fsp3:  0.189
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.097
MDCK Permeability:  2.7266049073659815e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.231
20% Bioavailability (F20%):  0.001
30% Bioavailability (F30%):  0.001

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.0
Plasma Protein Binding (PPB):  83.63459777832031%
Volume Distribution (VD):  0.323
Pgp-substrate:  44.6328010559082%

ADMET: Metabolism

CYP1A2-inhibitor:  0.053
CYP1A2-substrate:  0.978
CYP2C19-inhibitor:  0.198
CYP2C19-substrate:  0.079
CYP2C9-inhibitor:  0.829
CYP2C9-substrate:  0.879
CYP2D6-inhibitor:  0.0
CYP2D6-substrate:  0.332
CYP3A4-inhibitor:  0.088
CYP3A4-substrate:  0.398

ADMET: Excretion

Clearance (CL):  1.272
Half-life (T1/2):  0.394

ADMET: Toxicity

hERG Blockers:  0.055
Human Hepatotoxicity (H-HT):  0.147
Drug-inuced Liver Injury (DILI):  0.996
AMES Toxicity:  0.324
Rat Oral Acute Toxicity:  0.5
Maximum Recommended Daily Dose:  0.025
Skin Sensitization:  0.66
Carcinogencity:  0.022
Eye Corrosion:  0.003
Eye Irritation:  0.388
Respiratory Toxicity:  0.02

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC99591

Natural Product ID:  NPC99591
Common Name*:   Methylenebissantin
IUPAC Name:   8-[[5,7-dihydroxy-3,6-dimethoxy-2-(4-methoxyphenyl)-4-oxochromen-8-yl]methyl]-5,7-dihydroxy-3,6-dimethoxy-2-(4-methoxyphenyl)chromen-4-one
Synonyms:   Methylenebissantin
Standard InCHIKey:  PCEQWQQXZCRNCK-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C37H32O14/c1-44-18-11-7-16(8-12-18)30-36(48-5)28(42)22-26(40)34(46-3)24(38)20(32(22)50-30)15-21-25(39)35(47-4)27(41)23-29(43)37(49-6)31(51-33(21)23)17-9-13-19(45-2)14-10-17/h7-14,38-41H,15H2,1-6H3
SMILES:  COc1ccc(cc1)c1c(c(=O)c2c(c(c(c(Cc3c(c(c(c4c(=O)c(c(c5ccc(cc5)OC)oc34)OC)O)OC)O)c2o1)O)OC)O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1933858
PubChem CID:   56835122
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0002585] O-methylated flavonoids
          • [CHEMONTID:0002591] 6-O-methylated flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19123 Polygonatum zanlanscianense Species Asparagaceae Eukaryota n.a. n.a. n.a. PMID[15620239]
NPO19123 Polygonatum zanlanscianense Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO19123 Polygonatum zanlanscianense Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO5452 Curcuma parviflora Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO3010 Nidorella hottentotica Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO26259 Streptomyces rimofaciens Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[UNPD]
NPO19123 Polygonatum zanlanscianense Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO16448 Corydalis pseudoadunca Species Papaveraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1333 Individual Protein Enoyl-acyl-carrier protein reductase Plasmodium falciparum IC50 = 91130.0 nM PMID[522888]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC99591 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9506 High Similarity NPC272064
0.9383 High Similarity NPC196179
0.9383 High Similarity NPC34089
0.9345 High Similarity NPC216307
0.9329 High Similarity NPC259757
0.9321 High Similarity NPC246478
0.9277 High Similarity NPC475212
0.9273 High Similarity NPC470462
0.9268 High Similarity NPC470459
0.9259 High Similarity NPC9609
0.9259 High Similarity NPC25495
0.9259 High Similarity NPC261004
0.9259 High Similarity NPC19687
0.9259 High Similarity NPC18607
0.9259 High Similarity NPC143828
0.9259 High Similarity NPC176300
0.9259 High Similarity NPC253634
0.9259 High Similarity NPC105242
0.9259 High Similarity NPC22472
0.9259 High Similarity NPC130894
0.9259 High Similarity NPC152166
0.9259 High Similarity NPC204854
0.9259 High Similarity NPC7846
0.9259 High Similarity NPC300943
0.9259 High Similarity NPC288669
0.9259 High Similarity NPC191459
0.9259 High Similarity NPC4481
0.9259 High Similarity NPC18772
0.9259 High Similarity NPC115798
0.9235 High Similarity NPC324742
0.9217 High Similarity NPC470456
0.9217 High Similarity NPC295082
0.9217 High Similarity NPC158761
0.9212 High Similarity NPC470457
0.9202 High Similarity NPC188967
0.9198 High Similarity NPC203891
0.9198 High Similarity NPC112954
0.9198 High Similarity NPC305663
0.9198 High Similarity NPC101830
0.9198 High Similarity NPC78302
0.9198 High Similarity NPC287979
0.9198 High Similarity NPC163524
0.9198 High Similarity NPC75215
0.9198 High Similarity NPC472438
0.9198 High Similarity NPC110070
0.9198 High Similarity NPC176665
0.9198 High Similarity NPC224137
0.9198 High Similarity NPC189179
0.9198 High Similarity NPC29841
0.9198 High Similarity NPC93376
0.9198 High Similarity NPC235215
0.9198 High Similarity NPC183
0.9198 High Similarity NPC227192
0.9198 High Similarity NPC7973
0.9167 High Similarity NPC476370
0.9162 High Similarity NPC280493
0.9162 High Similarity NPC107627
0.9157 High Similarity NPC272560
0.9146 High Similarity NPC259456
0.9141 High Similarity NPC154304
0.9141 High Similarity NPC190487
0.9141 High Similarity NPC193842
0.9136 High Similarity NPC49824
0.9136 High Similarity NPC98661
0.9136 High Similarity NPC43243
0.9136 High Similarity NPC247017
0.9136 High Similarity NPC178854
0.9136 High Similarity NPC268161
0.9136 High Similarity NPC292107
0.9136 High Similarity NPC266960
0.9136 High Similarity NPC245546
0.9136 High Similarity NPC200388
0.9136 High Similarity NPC100916
0.9136 High Similarity NPC55619
0.9136 High Similarity NPC474520
0.9112 High Similarity NPC476374
0.9102 High Similarity NPC243877
0.9102 High Similarity NPC260266
0.9096 High Similarity NPC477840
0.9096 High Similarity NPC50960
0.9091 High Similarity NPC83922
0.9091 High Similarity NPC261470
0.9091 High Similarity NPC472448
0.9091 High Similarity NPC219927
0.9085 High Similarity NPC204290
0.9085 High Similarity NPC476980
0.908 High Similarity NPC218871
0.908 High Similarity NPC64755
0.908 High Similarity NPC237418
0.908 High Similarity NPC78225
0.908 High Similarity NPC476630
0.908 High Similarity NPC185526
0.9074 High Similarity NPC167815
0.9074 High Similarity NPC92659
0.9074 High Similarity NPC227325
0.9074 High Similarity NPC189960
0.9074 High Similarity NPC201136
0.9074 High Similarity NPC44079
0.9074 High Similarity NPC146165
0.9074 High Similarity NPC2476
0.9074 High Similarity NPC26227
0.9074 High Similarity NPC32557
0.9074 High Similarity NPC128863
0.9074 High Similarity NPC138360
0.9074 High Similarity NPC280339
0.9074 High Similarity NPC50715
0.9074 High Similarity NPC183597
0.9074 High Similarity NPC133392
0.9074 High Similarity NPC196439
0.9074 High Similarity NPC214138
0.9074 High Similarity NPC163780
0.9074 High Similarity NPC201451
0.9074 High Similarity NPC4455
0.9053 High Similarity NPC472454
0.9053 High Similarity NPC186847
0.9053 High Similarity NPC257667
0.9048 High Similarity NPC177480
0.9042 High Similarity NPC320741
0.9042 High Similarity NPC171985
0.9042 High Similarity NPC39091
0.9036 High Similarity NPC41301
0.903 High Similarity NPC167678
0.903 High Similarity NPC29876
0.903 High Similarity NPC258331
0.903 High Similarity NPC198829
0.903 High Similarity NPC40037
0.903 High Similarity NPC266314
0.9024 High Similarity NPC469658
0.9018 High Similarity NPC265511
0.9018 High Similarity NPC191146
0.9018 High Similarity NPC276444
0.9018 High Similarity NPC471985
0.9018 High Similarity NPC68093
0.9017 High Similarity NPC150977
0.9012 High Similarity NPC476631
0.9012 High Similarity NPC236223
0.9012 High Similarity NPC231018
0.9012 High Similarity NPC176775
0.9012 High Similarity NPC274327
0.9012 High Similarity NPC183878
0.9012 High Similarity NPC276409
0.9012 High Similarity NPC145379
0.9012 High Similarity NPC162351
0.9012 High Similarity NPC185275
0.9012 High Similarity NPC246204
0.9012 High Similarity NPC255350
0.9012 High Similarity NPC75279
0.9012 High Similarity NPC160951
0.9012 High Similarity NPC179126
0.9012 High Similarity NPC78326
0.9012 High Similarity NPC270620
0.9012 High Similarity NPC58382
0.9012 High Similarity NPC47781
0.9012 High Similarity NPC86485
0.9012 High Similarity NPC250822
0.9012 High Similarity NPC22519
0.9012 High Similarity NPC69394
0.9006 High Similarity NPC49667
0.9006 High Similarity NPC8127
0.9 High Similarity NPC149846
0.8994 High Similarity NPC476365
0.8988 High Similarity NPC14662
0.8982 High Similarity NPC7688
0.8982 High Similarity NPC36
0.8982 High Similarity NPC472450
0.8982 High Similarity NPC239752
0.8982 High Similarity NPC275780
0.8982 High Similarity NPC72787
0.8982 High Similarity NPC36916
0.8982 High Similarity NPC7154
0.8982 High Similarity NPC125039
0.8982 High Similarity NPC280893
0.8982 High Similarity NPC58223
0.8976 High Similarity NPC194427
0.8976 High Similarity NPC477841
0.8976 High Similarity NPC78332
0.8966 High Similarity NPC148710
0.8963 High Similarity NPC476981
0.8963 High Similarity NPC262286
0.8963 High Similarity NPC36852
0.8957 High Similarity NPC208197
0.8957 High Similarity NPC256612
0.8957 High Similarity NPC213622
0.8957 High Similarity NPC20830
0.8953 High Similarity NPC265380
0.8953 High Similarity NPC168584
0.8951 High Similarity NPC222830
0.8951 High Similarity NPC198826
0.8951 High Similarity NPC57030
0.8951 High Similarity NPC120163
0.8951 High Similarity NPC82325
0.8951 High Similarity NPC212678
0.8951 High Similarity NPC63187
0.8951 High Similarity NPC293183
0.8951 High Similarity NPC256283
0.8951 High Similarity NPC249570
0.8951 High Similarity NPC27208
0.8951 High Similarity NPC279989
0.8951 High Similarity NPC123886
0.8951 High Similarity NPC239128

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC99591 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9012 High Similarity NPD2801 Approved
0.8982 High Similarity NPD6166 Phase 2
0.8982 High Similarity NPD6167 Clinical (unspecified phase)
0.8982 High Similarity NPD6168 Clinical (unspecified phase)
0.8675 High Similarity NPD3882 Suspended
0.8667 High Similarity NPD2393 Clinical (unspecified phase)
0.8621 High Similarity NPD4338 Clinical (unspecified phase)
0.8621 High Similarity NPD7808 Phase 3
0.8614 High Similarity NPD3817 Phase 2
0.8606 High Similarity NPD1934 Approved
0.858 High Similarity NPD1512 Approved
0.8563 High Similarity NPD7251 Discontinued
0.8519 High Similarity NPD4378 Clinical (unspecified phase)
0.8506 High Similarity NPD6797 Phase 2
0.8506 High Similarity NPD7993 Clinical (unspecified phase)
0.8497 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8497 Intermediate Similarity NPD7054 Approved
0.8457 Intermediate Similarity NPD1511 Approved
0.8448 Intermediate Similarity NPD7472 Approved
0.8448 Intermediate Similarity NPD7074 Phase 3
0.8402 Intermediate Similarity NPD7075 Discontinued
0.8382 Intermediate Similarity NPD7473 Discontinued
0.8343 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD3818 Discontinued
0.8314 Intermediate Similarity NPD6232 Discontinued
0.8304 Intermediate Similarity NPD5494 Approved
0.8293 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8284 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8284 Intermediate Similarity NPD5402 Approved
0.8263 Intermediate Similarity NPD4380 Phase 2
0.8256 Intermediate Similarity NPD6959 Discontinued
0.8232 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8225 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8166 Intermediate Similarity NPD6801 Discontinued
0.815 Intermediate Similarity NPD1247 Approved
0.8114 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8079 Intermediate Similarity NPD5844 Phase 1
0.8043 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8023 Intermediate Similarity NPD7768 Phase 2
0.8012 Intermediate Similarity NPD7819 Suspended
0.8 Intermediate Similarity NPD7411 Suspended
0.7977 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7904 Intermediate Similarity NPD6799 Approved
0.787 Intermediate Similarity NPD5403 Approved
0.7853 Intermediate Similarity NPD3926 Phase 2
0.7829 Intermediate Similarity NPD919 Approved
0.7803 Intermediate Similarity NPD1465 Phase 2
0.7758 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7751 Intermediate Similarity NPD5401 Approved
0.7744 Intermediate Similarity NPD1510 Phase 2
0.7733 Intermediate Similarity NPD6599 Discontinued
0.7711 Intermediate Similarity NPD1549 Phase 2
0.7697 Intermediate Similarity NPD2796 Approved
0.7692 Intermediate Similarity NPD7390 Discontinued
0.7684 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7676 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7663 Intermediate Similarity NPD8312 Approved
0.7663 Intermediate Similarity NPD8313 Approved
0.765 Intermediate Similarity NPD6559 Discontinued
0.7607 Intermediate Similarity NPD1240 Approved
0.7607 Intermediate Similarity NPD943 Approved
0.7598 Intermediate Similarity NPD3787 Discontinued
0.759 Intermediate Similarity NPD2935 Discontinued
0.7571 Intermediate Similarity NPD3749 Approved
0.7558 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7556 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7538 Intermediate Similarity NPD7435 Discontinued
0.7527 Intermediate Similarity NPD3751 Discontinued
0.7515 Intermediate Similarity NPD1607 Approved
0.75 Intermediate Similarity NPD7870 Phase 2
0.75 Intermediate Similarity NPD7871 Phase 2
0.7474 Intermediate Similarity NPD6778 Approved
0.7474 Intermediate Similarity NPD6779 Approved
0.7474 Intermediate Similarity NPD6781 Approved
0.7474 Intermediate Similarity NPD6780 Approved
0.7474 Intermediate Similarity NPD6782 Approved
0.7474 Intermediate Similarity NPD6776 Approved
0.7474 Intermediate Similarity NPD6777 Approved
0.7471 Intermediate Similarity NPD6190 Approved
0.7456 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD2800 Approved
0.7449 Intermediate Similarity NPD7696 Phase 3
0.7449 Intermediate Similarity NPD7697 Approved
0.7449 Intermediate Similarity NPD7698 Approved
0.7447 Intermediate Similarity NPD8150 Discontinued
0.7442 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD3750 Approved
0.74 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD7874 Approved
0.7396 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7387 Intermediate Similarity NPD7701 Phase 2
0.7385 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD3226 Approved
0.7362 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.735 Intermediate Similarity NPD8151 Discontinued
0.7348 Intermediate Similarity NPD7199 Phase 2
0.7341 Intermediate Similarity NPD2534 Approved
0.7341 Intermediate Similarity NPD2532 Approved
0.7341 Intermediate Similarity NPD2533 Approved
0.7337 Intermediate Similarity NPD7228 Approved
0.7333 Intermediate Similarity NPD6234 Discontinued
0.7321 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD6651 Approved
0.7303 Intermediate Similarity NPD8455 Phase 2
0.7301 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD1613 Approved
0.7289 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD7699 Phase 2
0.7282 Intermediate Similarity NPD7700 Phase 2
0.7277 Intermediate Similarity NPD7801 Approved
0.7277 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7277 Intermediate Similarity NPD7783 Phase 2
0.7263 Intermediate Similarity NPD8434 Phase 2
0.7257 Intermediate Similarity NPD920 Approved
0.7246 Intermediate Similarity NPD447 Suspended
0.7246 Intermediate Similarity NPD230 Phase 1
0.7219 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD5953 Discontinued
0.7216 Intermediate Similarity NPD6535 Approved
0.7216 Intermediate Similarity NPD6534 Approved
0.7216 Intermediate Similarity NPD1653 Approved
0.7212 Intermediate Similarity NPD3027 Phase 3
0.7204 Intermediate Similarity NPD7286 Phase 2
0.7181 Intermediate Similarity NPD7685 Pre-registration
0.7169 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD2313 Discontinued
0.7169 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD37 Approved
0.7151 Intermediate Similarity NPD1243 Approved
0.7143 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7136 Intermediate Similarity NPD6823 Phase 2
0.7135 Intermediate Similarity NPD2344 Approved
0.7135 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7129 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7127 Intermediate Similarity NPD4965 Approved
0.7127 Intermediate Similarity NPD4967 Phase 2
0.7127 Intermediate Similarity NPD4966 Approved
0.7126 Intermediate Similarity NPD6233 Phase 2
0.7118 Intermediate Similarity NPD2799 Discontinued
0.7118 Intermediate Similarity NPD3748 Approved
0.7079 Intermediate Similarity NPD7458 Discontinued
0.7076 Intermediate Similarity NPD1551 Phase 2
0.7076 Intermediate Similarity NPD6099 Approved
0.7076 Intermediate Similarity NPD6100 Approved
0.7066 Intermediate Similarity NPD6798 Discontinued
0.7065 Intermediate Similarity NPD8319 Approved
0.7065 Intermediate Similarity NPD8320 Phase 1
0.7048 Intermediate Similarity NPD4908 Phase 1
0.7035 Intermediate Similarity NPD2346 Discontinued
0.7029 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD7229 Phase 3
0.7011 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD4628 Phase 3
0.6995 Remote Similarity NPD7584 Approved
0.6988 Remote Similarity NPD9494 Approved
0.6977 Remote Similarity NPD5408 Approved
0.6977 Remote Similarity NPD5404 Approved
0.6977 Remote Similarity NPD5406 Approved
0.6977 Remote Similarity NPD5405 Approved
0.6973 Remote Similarity NPD8127 Discontinued
0.6971 Remote Similarity NPD2309 Approved
0.6967 Remote Similarity NPD7907 Approved
0.6963 Remote Similarity NPD7549 Discontinued
0.6961 Remote Similarity NPD6844 Discontinued
0.6954 Remote Similarity NPD4360 Phase 2
0.6954 Remote Similarity NPD4363 Phase 3
0.6952 Remote Similarity NPD2403 Approved
0.6951 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6941 Remote Similarity NPD1933 Approved
0.6914 Remote Similarity NPD8166 Discontinued
0.6914 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6911 Remote Similarity NPD7240 Approved
0.6882 Remote Similarity NPD4060 Phase 1
0.6854 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6845 Remote Similarity NPD5710 Approved
0.6845 Remote Similarity NPD6832 Phase 2
0.6845 Remote Similarity NPD5711 Approved
0.6842 Remote Similarity NPD6355 Discontinued
0.6832 Remote Similarity NPD2493 Approved
0.6832 Remote Similarity NPD2494 Approved
0.6818 Remote Similarity NPD6213 Phase 3
0.6818 Remote Similarity NPD7003 Approved
0.6818 Remote Similarity NPD6212 Phase 3
0.6818 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6813 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6809 Remote Similarity NPD5242 Approved
0.6805 Remote Similarity NPD7095 Approved
0.6804 Remote Similarity NPD8054 Approved
0.6804 Remote Similarity NPD8053 Approved
0.6796 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6789 Remote Similarity NPD7177 Discontinued
0.678 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6766 Remote Similarity NPD1203 Approved
0.6765 Remote Similarity NPD7680 Approved
0.6765 Remote Similarity NPD3268 Approved
0.6751 Remote Similarity NPD4287 Approved
0.675 Remote Similarity NPD4362 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data